We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 82,621

eCTD Format Required for all Mutual Recognition Procedure Submissions
  • Hogan Lovells
  • European Union
  • January 19 2018

Despite earlier recommendations to the contrary, as of 1 January 2018 all types of EU mutual recognition procedure (“MRP”) submissions should be made


When is circumstantial evidence enough? Lessons from Re SUN and Re
  • Rubin Thomlinson LLP
  • Canada
  • January 19 2018

Re SUN and Regina Qu'Appelle Regional Health Authority (2017 CanLII 87132 (SK LA)) is a cautionary tale for any employer who has ever relied upon


New SAMHSA Rule: Permissible Part 2 Substance Abuse Disclosures to Subcontractors
  • Baker Donelson
  • USA
  • January 18 2018

On January 3, 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule to revise 42 CFR Part 2, the federal


When is an exclusive licence not an exclusive licence? - Common sense and the present tense prevail!
  • Brodies LLP
  • United Kingdom
  • January 18 2018

A recent judgement of the English High Court decided an important new point on what amounts to an exclusive patent licence. In the case of Oxford


Ringing in the New Year with New Medicare Payment Rates for Physicians, Hospitals and Ambulatory Surgery Centers
  • Drinker Biddle & Reath LLP
  • USA
  • January 18 2018

The Centers for Medicare and Medicaid Services’ (CMS) final rules1 updating the Quality Reporting Program and Medicare payment rates for the Hospital


Congress Holds More Hearings on Opioid Crisis and Public Health Threats
  • Reed Smith LLP
  • USA
  • January 18 2018

A number of recent Congressional hearings focused on the opioid crisis, including the following: A House Ways and Means Oversight Subcommittee


Biosimilar Market Developments Continue Apace in 2018
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • January 18 2018

It has been a few months since we reported on Federal Court wranglings with the Biologics Price Competition and Innovation Act, or BPCIA, which


HHS Delays Compliance Date for Revised Common Rule
  • Ropes & Gray LLP
  • USA
  • January 18 2018

On January 17, 2018, just two days before a final rule that revised the Common Rule was scheduled to take effect, the United States Department of


Cannabis au travail : les employeurs invités à passer à l’action
  • Stikeman Elliott LLP
  • Canada
  • January 18 2018

L’usage de la marihuana à des fins médicales est actuellement légal au Canada et on s’attend à ce que la consommation récréative de marihuana soit


Senate committee approves Trump pick for Health Secretary who vowed to tackle ‘gaming’ of the patent system
  • IAM
  • USA
  • January 18 2018

President Trump’s nominee for Secretary of Health and Human Services, Alex Azar, was approved by the Senate Finance Committee yesterday, taking him